The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds
Authors:
- Emily J. PrewettEPEmily J. Prewett
- Af M. SawyerrASAf M. Sawyerr
- Mark HudsonMHMark Hudson
- Roy E. PounderRPRoy E. Pounder
- 1 October 1991
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 101 (4) , 889-894
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Transmucosal penetration of bismuth particles in the human stomachGastroenterology, 1992
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990
- The absorption of bismuth and salicylate from oral doses of Pepto‐Bismol (bismuth salicylate)Alimentary Pharmacology & Therapeutics, 1990
- Campylobacter pylori and Peptic Ulcer DiseaseGastroenterology, 1989
- The absorption of bismuth from oral doses of tripotassium dicitrato bismuthateAlimentary Pharmacology & Therapeutics, 1989
- CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDYThe Lancet, 1987
- Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.BMJ, 1986
- The ultrastructural localisation of de‐nol (colloidal tripotassium dicitrato‐bismuthate—TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administrationThe Journal of Pathology, 1983
- Absorption of salicylate and bismuth from a bismuthsubsalicylate-containing compound (Pepto-Bismol)The Journal of Pediatrics, 1981
- Determination of bismuth in blood and urineThe Analyst, 1976